Paracrine CCL20 has been shown to induce epithelial-mesenchymal transition in breast cancer [48,49] and CCL5 has been shown to promote vascular endothelial growth factor VEGF-induced angiogenesis [50]. This evidence concerns the gene CCL5 and breast carcinoma.